ARCHIVES

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

This article is from The Cancer Letter archive.

Vol. 38 No. 05 | February 3, 2012

Download PDF Visit The Full Archive

Related Articles

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma

September 25, 2009

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

Includes June issue of Business & Regulatory Report.

June 28, 2002

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974